Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2600 to 2649 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2600\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HYAL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
interferon-related developmental regulator 2 (skmc15 protein). [source:swissprot;acc:q12894]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.877\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.193\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00141\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2601\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CNNM3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cyclin m3; ancient conserved domain protein 3. [source:refseq;acc:nm\_017623]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.502\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.2\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2602\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARPC5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
arp2/3 complex 16 kda subunit (p16-arc) (actin-related protein 2/3 complex subunit 5). [source:swissprot;acc:o15511]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.875\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.192\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2603\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CNNM4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cyclin m4; ancient conserved domain protein 4. [source:refseq;acc:nm\_020184]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.494\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.192\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2604\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CNNM2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cyclin m2; ancient conserved domain protein 2. [source:refseq;acc:nm\_017649]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.486\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.184\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2605\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRUNE\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tcd37 homolog; prune. [source:refseq;acc:nm\_021222]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.495\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.193\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2606\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CNNM1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cyclin m1; ancient conserved domain protein 1. [source:refseq;acc:nm\_020348]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.198\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2607\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRPS22\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial 28s ribosomal protein s22 (s22mt) (mrp-s22) (gk002). [source:swissprot;acc:p82650]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.497\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
215.799\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0014\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2608\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nefa-interacting nuclear protein nip30. [source:refseq;acc:nm\_024946]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2609\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LMX1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lim homeobox transcription factor 1 alpha (lim/homeobox protein lmx1a) (lim-homeobox protein 1.1) (lmx-1.1). [source:swissprot;acc:q8te12]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2610\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TOMM70A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial precursor proteins import receptor (translocase of outer membrane tom70). [source:swissprot;acc:o94826]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2611\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LMX1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lim homeobox transcription factor 1 beta (lim/homeobox protein lmx1b) (lim-homeobox protein 1.2) (lmx-1.2). [source:swissprot;acc:o60663]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2612\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
proteasome subunit beta type 2 (ec 3.4.25.1) (proteasome component c7-i) (macropain subunit c7-i) (multicatalytic endopeptidase complex subunit c7-i). [source:swissprot;acc:p49721]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2613\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 1. [source:swissprot;acc:p40616]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2614\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RELA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor p65 (nuclear factor nf-kappa-b p65 subunit). [source:swissprot;acc:q04206]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
202.821\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
202.54\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00139\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2615\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RELB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor relb (i-rel). [source:swissprot;acc:q01201]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2616\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NFKBIA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nf-kappab inhibitor alpha (major histocompatibility complex enhancer- binding protein mad3) (i-kappa-b-alpha) (ikappabalpha) (ikb-alpha). [source:swissprot;acc:p25963]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2617\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPOX\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
coproporphyrinogen iii oxidase, mitochondrial precursor (ec 1.3.3.3) (coproporphyrinogenase) (coprogen oxidase) (cox). [source:swissprot;acc:p36551]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2618\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IDH2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
isocitrate dehydrogenase [nadp], mitochondrial precursor (ec 1.1.1.42) (oxalosuccinate decarboxylase) (idh) (nadp+-specific icdh) (idp) (icd-m). [source:swissprot;acc:p48735]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
190.166\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.429\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00138\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2619\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SMARCC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
swi/snf-related matrix-associated actin-dependent regulator of chromatin c2 isoform a; mammalian chromatin remodeling complex brg1-associated factor 170; chromatin remodeling complex baf170 subunit; swi3-like protein; swi/snf complex 170 kda subunit. [source:refseq;acc:nm\_003075]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.024\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.722\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00137\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2620\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMD9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 9 (26s proteasome regulatory subunit p27). [source:swissprot;acc:o00233]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.615\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.91\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2621\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dj470l14.3 (novel protein similar to the arp2/3 protein complex subunit p21-arc (arc21)). [source:sptrembl;acc:q9h5b6]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
224.891\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
225.195\vspace{3pt}}}&\multirow{14}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00135\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2622\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZMYM6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 258. [source:refseq;acc:nm\_145310]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2623\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZMYM3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 261 (dxs6673e protein). [source:swissprot;acc:q14202]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2624\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZMYM4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 262; cell death inhibiting rna. [source:refseq;acc:nm\_005095]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2625\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WTAP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
wilms' tumor 1-associating protein (wt1-associated protein). [source:swissprot;acc:q15007]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.304\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.028\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2626\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACTR2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
actin-like protein 2 (actin-related protein 2). [source:swissprot;acc:o15142]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
224.891\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
225.195\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2627\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COG3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 3 (vesicle docking protein sec34 homolog) (p94). [source:swissprot;acc:q96jb2]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2628\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACTR3B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
similar to actin-related protein 3-beta. [source:sptrembl;acc:q96bt2]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2629\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARPC1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
arp2/3 complex 41 kda subunit (p41-arc) (actin-related protein 2/3 complex subunit 1b). [source:swissprot;acc:o15143]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2630\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZMYM2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 198 (fused in myeloproliferative disorders protein) (rearranged in atypical myeloproliferative disorder protein). [source:swissprot;acc:q9ubw7]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2631\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACTR3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
actin-like protein 3 (actin-related protein 3) (actin-2). [source:swissprot;acc:p32391]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2632\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARPC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
arp2/3 complex 21 kda subunit (p21-arc) (actin-related protein 2/3 complex subunit 3). [source:swissprot;acc:o15145]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2633\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NRD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nardilysin precursor (ec 3.4.24.61) (n-arginine dibasic convertase) (nrd convertase) (nrd-c). [source:swissprot;acc:o43847]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2634\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARPC1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
actin-related protein 2/3 complex subunit 1a (sop2-like protein). [source:swissprot;acc:q92747]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2635\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CLP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pre-mrna cleavage complex ii protein clp1. [source:swissprot;acc:q92989]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
166.612\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
166.393\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00132\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2636\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ANAPC11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
anaphase promoting complex subunit 11 (hepatocellular carcinoma associated ring finger protein) (hspc214). [source:swissprot;acc:q9nyg5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
195.635\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
195.384\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00128\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2637\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
small glutamine rich protein with tetratricopeptide repeats 2. [source:refseq;acc:nm\_019072]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.075\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
186.84\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00126\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2638\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
F11R\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
junctional adhesion molecule 1 precursor (jam) (platelet adhesion molecule 1) (pam-1) (platelet f11 receptor). [source:swissprot;acc:q9y624]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.911\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.168\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00125\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2639\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYO7A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin viia. [source:swissprot;acc:q13402]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.658\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
220.386\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00123\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2640\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBE2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 b (ec 6.3.2.19) (ubiquitin-protein ligase b) (ubiquitin carrier protein b) (hr6b) (hhr6b) (e2-17 kda). [source:swissprot;acc:p23567]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2641\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBE2A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 a (ec 6.3.2.19) (ubiquitin-protein ligase a) (ubiquitin carrier protein a) (hr6a) (hhr6a). [source:swissprot;acc:p49459]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2642\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TOPBP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
topoisomerase (dna) ii binding protein. [source:refseq;acc:nm\_007027]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
194.097\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
194.328\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00119\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2643\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACOX1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
acyl-coenzyme a oxidase 1, peroxisomal (ec 1.3.3.6) (palmitoyl-coa oxidase) (aox). [source:swissprot;acc:q15067]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2644\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP5J2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atp synthase f chain, mitochondrial (ec 3.6.3.14). [source:swissprot;acc:p56134]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2645\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DHX35\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
probable atp-dependent helicase ddx35 (deah-box protein 35). [source:swissprot;acc:q9h5z1]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2646\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TSC22D4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tsc22-related inducible leucine zipper protein 2 (tsc-22-like protein thg-1). [source:swissprot;acc:q9y3q8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.169\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.417\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00116\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2647\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAT1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
s-adenosylmethionine synthetase alpha and beta forms (ec 2.5.1.6) (methionine adenosyltransferase) (adomet synthetase) (mat-i/iii). [source:swissprot;acc:q00266]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.496\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.25\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2648\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DEGS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sphingolipid delta 4 desaturase; membrane fatty acid (lipid) desaturase; dihydroceramide desaturase. [source:refseq;acc:nm\_003676]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.169\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.417\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2649\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nif3-like protein 1 (amyotrophic lateral sclerosis 2 chromosomal region candidate gene protein 1) (my018 protein) (mds015). [source:swissprot;acc:q9gzt8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.874\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00114\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/